Contineum Therapeutics(Ctnm) Financials: Operating Profit Margin Compared To Industry Average, Plus Other Key Ratios
Company Report for CTNM
Report - operating profit margin
This chart shows the historical trend of operating profit margin for CTNM compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Operating Profit Margin
Definition: Operating profit margin focuses on profits from the company’s core business — before interest payments and taxes. It reflects how well the business manages operating costs relative to sales. Strong operating margins show efficient day-to-day operations. Shrinking margins may reveal rising overhead, pricing weakness, or declining efficiency.
Interpretation:
• In '2023', CTNM's operating profit margin was 32.1%, highlighting profit earned from core business operations. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at -144.9%.
Overall, CTNM's operating profit margin has remained generally stable over the past 1 years.
Formula: Operating Profit Margin = Operating Income / Revenue
Good Range: Often 10%-30% depending on business model.